1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design.

Christopher Blackburn, Cynthia Barrett, Janice Chin, Kris Garcia, Kenneth Gigstad, Alexandra Gould, Juan Gutierrez, Sean Harrison, Kara Hoar, Chrissie Lynch, R. Scott Rowland, Chris Tsu, John Ringeling, He Xu, Potent Histone Deacetylase Inhibitors Derived from 4-(Aminomethyl)-N-hydroxybenzamide with High Selectivity for the HDAC6 Isoform Journal of Medicinal Chemistry. ,vol. 56, pp. 7201- 7211 ,(2013) , 10.1021/JM400385R

Yingjie Zhang, Hao Fang, Jinhong Feng, Yuping Jia, Xuejian Wang, Wenfang Xu, Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities. Journal of Medicinal Chemistry. ,vol. 54, pp. 5532- 5539 ,(2011) , 10.1021/JM200577A

James S. Scott, Andrew Bailey, Robert D. M. Davies, Sébastien L. Degorce, Philip A. MacFaul, Helen Gingell, Thomas Moss, Richard A. Norman, Jennifer H. Pink, Alfred A. Rabow, Bryan Roberts, Peter D. Smith, Tetrahydroisoquinoline Phenols: Selective Estrogen Receptor Downregulator Antagonists with Oral Bioavailability in Rat. ACS Medicinal Chemistry Letters. ,vol. 7, pp. 94- 99 ,(2016) , 10.1021/ACSMEDCHEMLETT.5B00413

Charles Ouellet, René Maltais, Étienne Ouellet, Xavier Barbeau, Patrick Lagüe, Donald Poirier, Discovery of a sulfamate-based steroid sulfatase inhibitor with intrinsic selective estrogen receptor modulator properties. European Journal of Medicinal Chemistry. ,vol. 119, pp. 169- 182 ,(2016) , 10.1016/J.EJMECH.2016.04.044

M. Puglisi, L. van Doorn, M. Blanco-Codesido, M. J. De Jonge, K. Moran, J. Yang, T. Busman, C. Franklin, M. Mabry, A. Krivoshik, R. Humerickhouse, L. R. Molife, F. Eskens, A phase I safety and pharmacokinetic (PK) study of navitoclax (N) in combination with docetaxel (D) in patients (pts) with solid tumors. Journal of Clinical Oncology. ,vol. 29, pp. 2518- 2518 ,(2011) , 10.1200/JCO.2011.29.15_SUPPL.2518

Wen Li, Han Zhang, Yehuda G. Assaraf, Kun Zhao, Xiaojun Xu, Jinbing Xie, Dong-Hua Yang, Zhe-Sheng Chen, Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies Drug Resistance Updates. ,vol. 27, pp. 14- 29 ,(2016) , 10.1016/J.DRUP.2016.05.001

Helen M. Coley, Overcoming Multidrug Resistance in Cancer: Clinical Studies of P-Glycoprotein Inhibitors Methods in Molecular Biology. ,vol. 596, pp. 341- 358 ,(2010) , 10.1007/978-1-60761-416-6_15

Darius Ebrahimi-Fakhari, Lara Wahlster, Fabian Bartz, Jennifer Werenbeck-Ueding, Maria Praggastis, Jessie Zhang, Brigitte Joggerst-Thomalla, Susanne Theiss, Dirk Grimm, Daniel S. Ory, Heiko Runz, Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells. Human Molecular Genetics. ,vol. 25, pp. 3588- 3599 ,(2016) , 10.1093/HMG/DDW204

Iljung Lee, Brian P. Lieberman, Shihong Li, Catherine Hou, Mehran Makvandi, Robert H. Mach, Comparative evaluation of 4 and 6-carbon spacer conformationally flexible tetrahydroisoquinolinyl benzamide analogues for imaging the sigma-2 receptor status of solid tumors. Nuclear Medicine and Biology. ,vol. 43, pp. 721- 731 ,(2016) , 10.1016/J.NUCMEDBIO.2016.08.001

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal, Cancer statistics, 2017 CA: A Cancer Journal for Clinicians. ,vol. 67, pp. 7- 30 ,(2017) , 10.3322/CAAC.21387